van Milligen F J, van 't Hof W, van den Berg M, Aalberse R C
Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam.
J Allergy Clin Immunol. 1994 Jan;93(1 Pt 1):34-43. doi: 10.1016/0091-6749(94)90230-5.
The major cat allergen Fel d I is composed of two disulfide-linked polypeptide chains, chain 1 (70 amino acid residues) and chain 2 (92 amino acid residues). Reduction and alkylation of Fel d I eliminates almost all antigenic and allergenic activity, and detection of linear epitopes with synthetic peptides is therefore not expected.
We synthesized synthetic peptides of both chains of about 14 amino acid residues, overlapping by 7 residues. The peptides were coupled to Sepharose (Pharmacia, Uppsala, Sweden) and tested with sera of patients with cat allergy.
Three peptides showed specific binding of human IgE, residues 25-38 and 46-59 of chain 1 and residue 15-28 of chain 2. IgE binding was inhibited by Fel d I and the corresponding peptide. Of 61 patients with cat allergy tested, 65% showed IgE binding to at least one of the peptides; 46% showed IgE binding to peptide 25-38, 11% to peptide 46-59, and 28% to peptide 15-28. Each peptide was recognized by only one of the 78 patients with negative RAST results. By affinity chromatography with peptide-Sepharose anti-Fel d I antibodies were isolated, also confirming the specificity of IgE binding to the peptides. The percentage of IgE antibodies against Fel d I reactive with the peptides varied with the serum and the peptide-Sepharose used and ranged from 2% to 55%.
Because the affinity of IgE binding to the peptides was very low and only serum samples with high titers of Fel d I-specific IgE antibodies (RAST 4+/5+) showed significant binding, these peptides are not suitable for diagnostic purposes. However, the peptides are useful tools for comparing IgE and IgG responses and for studying the relationship to the T-cell epitopes on this molecule.
主要的猫过敏原Fel d I由两条通过二硫键连接的多肽链组成,链1(70个氨基酸残基)和链2(92个氨基酸残基)。Fel d I的还原和烷基化几乎消除了所有抗原性和致敏活性,因此预计无法用合成肽检测线性表位。
我们合成了两条链的约14个氨基酸残基的合成肽,重叠7个残基。将这些肽偶联到琼脂糖凝胶(瑞典乌普萨拉的Pharmacia公司生产)上,并用对猫过敏患者的血清进行检测。
三种肽显示与人IgE特异性结合,链1的第25 - 38位残基和第46 - 59位残基以及链2的第15 - 28位残基。Fel d I和相应的肽可抑制IgE结合。在检测的61例对猫过敏的患者中,65%的患者显示IgE与至少一种肽结合;46%的患者显示IgE与肽25 - 38结合,11%与肽46 - 59结合,28%与肽15 - 28结合。在78例RAST结果为阴性的患者中,每种肽仅被其中1例识别。通过肽 - 琼脂糖凝胶亲和层析分离出抗Fel d I抗体,也证实了IgE与肽结合的特异性。与肽反应的抗Fel d I的IgE抗体百分比因血清和所用的肽 - 琼脂糖凝胶而异,范围为2%至55%。
由于IgE与肽的结合亲和力非常低,只有Fel d I特异性IgE抗体滴度高(RAST 4+/5+)的血清样本显示出显著结合,因此这些肽不适合用于诊断目的。然而,这些肽是比较IgE和IgG反应以及研究与该分子上T细胞表位关系的有用工具。